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CoughAbstract Objective: To compare the effectiveness of small dose of propofol or midazolam in
treating laryngospasm following extubation in adult patients undergoing oropharyngeal operations.
Methods: The study was conducted in Al-Zahra Hospital, Al-Azhar University, Egypt. One
hundred and twenty adult patients, with age range 30–50 years, ASA physical status I–II, of either
sex undergoing elective oropharyngeal surgeries under general anesthesia were randomly allocated
to one of three equal groups (n= 40) using a computer generated randomization table. At
extubation before suction, the patients in the three groups were administered intravenously propo-
fol 0.8 mg/kg diluted in 20 ml (Group P) or midazolam 0.05 mg/kg diluted in 20 ml (Group M) or
saline 20 ml as control group (Group C). The following parameters were recorded: hemodynamic
changes (heart rate and mean arterial blood pressure), the frequency and severity of laryngospasm
and cough were recorded before time of extubation and up to 5 min using four point scale.
Results: Compared with the control group, there was a significant decrease in the mean arterial
pressure and increase in pulse rate in both groups after administration of the study drugs and up
to 5 min after extubation, and this change was comparable and similar in both groups. During
emergence and up to 5 min, the incidence and severity of postoperative laryngospasm and cough
were significantly lower (p< 0.05) in both propofol and midazolam groups as compared to control
group. The change in both propofol and midazolam groups was insignificant and comparable.
Conclusion: We conclude that intravenous administration of small dose of propofol or midazolam
before tracheal extubation decreases the incidence and severity of laryngospasm and coughing in
adult patients undergoing oropharyngeal surgeries.
 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.56912.
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Laryngospasm and airway complications such as coughing
and oxygen desaturation are serious complications after
tracheal extubation [1]. Laryngospasm is considered a
physiological exaggeration of the glottis closure reflex. This
complication is more frequent in the following:
i. Children.
ii. Patients with airway infection.
iii. Those undergoing manipulation of the airway.
iv. Those using specific anesthetics.
v. Those undergoing oral or pharyngeal surgeries, and
vi. Smokers [2].
Extubation complications such as bucking, breath holding,
laryngospasm and pulmonary edema continue to be major
problems for the anesthesiologist, especially in oral surgery,
because at the end of surgery the mouth is full of secretions
and mixed blood and there is edema of the tissues. Deep
anesthesia will delay recovery while light plane may result in
coughing, breath holding efforts of self removal of tube, laryn-
gospasm, pulmonary edema [3], hypoxia and cardiac arrest [4].
There has been considerable research conducted on methods
and drugs to prevent coughing during emergence such as extu-
bation at a great anesthetic depth, the use of succinylcholine
[5], topical lignocaine [6], aerosolized lignocaine [7], nitroglyc-
erine [8], small dose of propofol [9], and magnesium [10]. These
methods all come with advantages and disadvantages.
Propofol is used widely in clinical anesthesia, and it is
known to be an inhibitor of airway reflexes [11]. It has been
reported that single i.v. administration of a subhypnotic dose
of propofol effectively prevents laryngospasm and coughing
during emergence in children [12,13].
As laryngospasm is considered a life-threatening condition,
it may increase the level of anxiety and in turn cause panic in
most individuals; panic in turn triggers an episode of asthma,
making this a vicious cycle, which can be broken by
midazolam.
Therefore, we have performed this study in order to analyze
the effects of small dose of propofol or midazolam on
preventing laryngospasm and cough during the emergence
from anesthesia following oropharyngeal surgeries.2. Patients and methods
We designed a prospective, randomized, and controlled
study using a computer–generated randomization table to
evaluate the efficacy of small dose propofol or midazolam toprevent laryngospasm and coughing following oropharyngeal
surgeries.
After approval from the local ethical committee, an
informed written consent was obtained from 120 patients of
American Society of Anesthesiologists (ASA) grade I & II,
age range between 30 and 50 years, of either sex scheduled
for elective oropharyngeal surgery (Uvulopalatopharyngo-
plasty (UPPP), Laryngoscopy with vocal cord surgery, Dental
surgery, and Arytenoidectomy) under general anesthesia in
Al-Zahra Hospitals, Al-Azhar University.
The duration of study was one year only from 2013 to 2014
and to get the unbiased results, the demographic matching was
necessary. Hence, a sample size of 120 patients to get the
preliminary trends was found to be feasible as shown in Fig. 1
Patients who received drugs such as lidocaine or a supple-
mental dose of narcotics before extubation were excluded from
the study; patients of ASA grade III/IV, those above 60 years
or below 12 years, and those with a full stomach were also
excluded. Patients with a history of bronchial asthma, allergy
especially chest, cardiovascular, or upper respiratory tract
diseases, smokers and obese patients with BMI greater than
35 kg/m2 were not enrolled in the study.
Patients were included in this study after a review of their
preoperative history, clinical examination and full investiga-
tion recorded in their hospital charts. Sedative premedication
drugs were not given to the patients. After arrival to the oper-
ation room, the patients were randomly divided into three
equal groups (40 patients each) by using computer generated
randomization table.
 Control group (c): saline 20 ml was given at the time of
extubation before suction.
 Propofol group (P): Propofol 0.8 mg/kg diluted in 20 ml
given intravenously at extubation before suction.
 Midazolam group (M): Midazolam 0.05 mg/kg diluted in
20 ml given intravenously at extubation before suction.
Upon arrival in the operating room, intravenous cannula
was inserted and electrocardiogram, non-invasive blood pres-
sure, pulse oximeter, and end tidal CO2 were applied to all
patients and their baseline vital signs were measured.
All patients were administered standard general anesthesia
consisting of thiopental (4 mg/kg), fentanyl (1–2 lg/kg), and
cisatracurium (0.15 mg/kg), administrated intravenously to
facilitate tracheal intubation using the appropriate size of
cuffed endotracheal tube. Anesthesia was maintained using
1–1.5% isoflurane in a mixture of oxygen and air at a ratio
of 50:50. Ventilation was controlled mechanically and adjusted
to maintain normocapnia (end tidal CO2 30–35 mmHg). The
vital data of the patients (noninvasive arterial blood pressure,
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Figure 1 Flow diagram of randomized controlled study.
Effect of small dose propofol or midazolam 15heart rate, oxygen saturation and end tidal carbon dioxide)
were monitored continuously throughout the surgery. Ade-
quate muscle relaxation during the operation was maintained
by 0.05 mg/kg of cisatracurium every 30 min. Increments in
dose of fentanyl 1 lg/kg were administered when there were
signs of inadequate anesthesia (e.g. increases in arterial pres-
sure greater than the target mean arterial pressure (MAP) or
tachycardia more than 90 beat/min). Patients received their
maintenance fluids (intravenous crystalloids) intraoperatively.
At the end of surgery, residual neuromuscular blockade was
antagonized using 0.05 mg/kg neostigmine and 0.01 mg/kg
atropine.
A trained assistant anesthetist, not part of the study, pre-
pared identical syringe with the study medication drugs. Three
minutes before suction and extubation, an anesthesiologist
injected the previously prepared study drugs for 10 s (propofol
0.8 mg/kg diluted in 20 ml normal saline for propofol group,
midazolam 0.05 mg/kg diluted in 20 ml normal saline for
midazolam group and 20 ml normal saline as control group).
Extubation of the endotracheal tube was performed when
the patient followed oral commands of ‘‘Open your eyes”
and showed regular spontaneous respiration, or when the
patient attempted self-extubation.
If laryngospasm occurs, removal of the irritant stimulus,
jaw thrust and administration of 100% oxygen are the first
steps in management. Oxygen therapy should be started with
a ‘T’ piece so that continuous positive airway pressure (CPAP)
might be initiated which often breaks the spasm. In the case of
prolongation of laryngeal spasm for more than 2 min after
treatment or a drop of saturation to less than 70%, intubation
is performed by administering 1 mg/kg succinylcholine and
ventilating with 100% O2.
The following parameter were recorded by anaesthesia
nurse blind to the patients’ group: (1) the incidence and
severity of postextubation coughing and laryngospasm
using four point scale. (2) The mean arterial pressure
(MAP) and heart rate (HR) were recorded before suction,
after suction and up to 5 min after extubation.2.1. Statistical analysis
The sample size was determined by referring previous studies
which reported that the incidence of coughing after general
anesthesia was 76% [14]. When it was hypothesized that using
propofol would reduce the occurrence of coughing to 50%, 25
patients are needed per group for a power analysis of 0.8
(a= 0.05, b= 0.2). Here, in anticipation of dropout, 40
patients per group, 120 patients in total, were determined. Sta-
tistical package for social science (SPSS) program version 17
(SPSS Inc, Chicago, Illinois, USA). The data were presented
as mean ± SD, when quantitative, or numbers and percent-
ages when qualitative. The following tests were done: A one-
way analysis of variance (ANOVA) was used when comparing
between more than two means and Chi-square (x2) test of sig-
nificance was used in order to compare proportions between
two qualitative parameters to analyze the incidence of baseline
and up to 5 min postoperative adverse events. Probability
(P-value) P-value <0.05 was considered significant, P-value
<0.001 was considered as highly significant, and P-value
>0.05 was considered insignificant.
3. Result
One hundred and twenty patients were enrolled in the study.
They were divided randomly into 3 equal groups (40 in each
group), Group C (control group), Group P (propofol group),
and Group M (midazolam group).
There were no significant differences between all groups
with regard to demographic data or ASA status, and types
and duration of surgeries, as shown in (Table 1).
Hemodynamic changes: Before suction (baseline value):
There were no significant differences between all groups as
regards hemodynamic changes (pulse rate and blood pressure).
After suction and up to first 5 min after extubation: In the
control group, there was significant increase in pulse rate and
blood pressure in comparison with the baseline value
(p< 0.001). In both Propofol and midazolam groups, there
Table 1 Patient characteristics and operation time (data represent as mean (SD) or number).
Variable Group (C) (n= 40) Group (P) Group (M) p-value
Age (Year) 39 ± 2.06 40 ± 3.9 38.5 ± 3.8 0.085a
Sex (male/female) 18/22 19/21 17/23 0.939
ASA (1/11) 35/5 37/3 33/7 0.401
Weight (kg) 80 ± 2.03 81 ± 3.9 79.4 ± 3.79 0.067a
Duration of surgery (min) 52 ± 3.22 50.9 ± 2.43 51 ± 1.61 0.089a
Type of surgery
Uvulopalatopharyngoplasty (UPPP) 13 14 10 0.927
Laryngoscopy with vocal cord surgery 11 12 15
Dental surgery 9 8 7
Arytenoidectomy 7 6 8
Data are expressed as mean ± SD for parametric data.
Data are expressed as frequency and percentage data.
a F – ANOVA test, Chi-square test.
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Figure 3 Mean pulse rate change (beat/min).
Table 2 Score of postextubation laryngospasm: (regardless of
its severity).
Four point scale
1 – No laryngospasm
2 – Mild laryngospasm (relieved by jaw thrust and 100% oxygen)
3 – Moderate laryngospasm (relieved by 100% oxygen and
positive pressure ventilation)
4 – Severe laryngospasm (relieved by succinyl choline and
intubation)
16 A.A. Shabanwas significant decrease in blood pressure and increase in pulse
rate in comparison with the baseline value which was significant
statistically, and these changes were comparable and
insignificant between both groups. Additionally, compared to
the control group, both groups showed significant decrease in
MAP and insignificant increase in pulse rate from the
discontinuation of anesthetic drugs to 5 min after extubation
as shown in Figs. 2 and 3.
Incidence of postoperative laryngospasm (regardless of its
severity) at time of extubation and up to 5 min was signifi-
cantly lower (p< 0.05) in propofol and midazolam groups
as compared to control group (see Tables 2–4).
Mild degree of laryngospasm was shown in 7 patients
(17.5%) in control group, 15 patients (37.5%) in propofol
group and 17 patients (42.5%) in midazolam group.
Moderate degree of laryngospasm was shown in 17 patients
(42.5%) in control group, 7 patients (17.5%) in propofol
group and 5 patients (12.5%) in midazolam group.
Sever degree of laryngospasm was shown in 12 patients
(30%) in control group, 2 patients (5%) in propofol group
and 4 patients (10%) in midazolam group.
The change in both propofol and midazolam groups was
insignificant and comparable.The incidence and grade of coughing during emergence was
significantly lower in the propofol and midazolam groups com-
pared to the control group. Grad (0) occur was shown in 4
patients (10%) in control group, 16 patients (40%) in propofol
and 17 patients (42.5%) in midazolam group. Grad (1) occur
was shown in 7 patients (17.5%) in control group, 16 patients
(40%) in propofol and 15 patients (37.5%) in midazolam
group. Grad (2) occur was shown in 14 patients (35%) in con-
trol group, 5 patients (17.5%) in propofol and 4 patients
(10%) in midazolam group. Grad (3) occur was shown in 15
Table 3 Incidence of severity of postoperative laryngospasm (data present as number percentage).
Group C (n= 40) Group P (n= 40) Group M (n= 40) Chi-square test
C vs. P C vs. M P vs. M
No laryngospasm 4 (10%) 16 (40%) 14 (35%) 0.007 0.018 0.715
Mild 7 (17.5%) 15 (37.5%) 17 (42.5%) 0.049 0.041 0.724
Moderate 17 (42.5%) 7 (17.5%) 5 (12.5%) 0.041 0.011 0.564
Severe 12 (30%) 2 (5%) 4 (10%) 0.008 0.046 0.414
Data are expressed as frequency and percentage data, Chi-square test.
Table 4 Score of postextubation cough: (regardless of its
severity).
Four Grads of cough
Grad 0: No cough
Grad 1: Single cough with mild severity
Grad 2: Cough persistence less than 5 s with moderate severity
Grad 3: Sever persistence cough more than 5 s
Effect of small dose propofol or midazolam 17patients (37.5%) in control group, 3 patients (7.5%) in propo-
fol and 4 patients (10%) in midazolam group. The change in
both propofol and midazolam groups was insignificant and
comparable as shown in Table 5.
4. Discussion
The main purpose of this study was to test the hypothesis that
intravenous administration of small dose of propofol or mida-
zolam before extubation would reduce the incidence and sever-
ity of postextubation laryngospasm and cough with safe
hemodynamic changes in patients undergoing elective oropha-
ryngeal surgeries.
Emergence from anesthesia and extubation induces variant
physiological responses including unwanted circulatory and
airway reflexes resulting in hypercirculatory manifestations in
the form of tachycardia and hypertension and cough, laryn-
gospasm, and bronchospasm. These events may predispose
or induce multiple complications either in the operative site
or elsewhere in the body [15].
Various methods have been studied to prevent coughing
during emergence from general anesthesia, such as extubation
in a deep plane of anesthesia [16], intra-cuff application of
lidocaine [17] or i.v. lidocaine [18], and administration of
dexmedetomidine [19] and remifentanil [20,21]. These methods
have various advantages, but they also have drawbacks so
their clinical use can be.Table 5 Incidence of severity of postoperative cough (data present
Group C (n= 40) Group P (n= 40) G
Grad 0 4 (10%) 16 (40%) 17
Grad 1 7 (17.5%) 16 (40%) 15
Grad 2 14 (35%) 5 (17.5%) 4
Grad 3 15 (37.5) 3 (7.5%) 4
Data are expressed as frequency and percentage data; Chi-square test.In this study, when a single dose of propofol 0.8 mg/kg was
administered at extubation before suction, it significantly
reduced the incidence and severity of coughing during emer-
gence as compared to control group, the NMDA inhibition
effect of propofol is less likely to be the main mechanism for
suppressing coughing, and there is need for more clinical stud-
ies regarding this matter. Such results are similar to a report
that the incidence of coughing was reduced in children when
propofol 0.25 mg/kg was used 1 min before extubation [13].
In our study the administration of (100%) O2 + jaw thrust
and positive pressure ventilation with the injection of intra-
venous drug therapy were done to relieve laryngospasm as well
as cyanosis in most patients.
Subhypnotic doses of propofol (0.25–0.8 lg/kg) have been
used previously for the treatment of postextubation laryn-
gospasm [22] and have proven effective. Propofol showed
rapid action with no side-effects such as bradycardia or
hypotension.
Benzodiazepines such as diazepam also decrease upper
airway reflexes and have been previously used orally by
Muphg et al. in the management and treatment of recurrent
postoperative laryngospasm, and midazolam has been
described to treat what is called psychogenic or hysterical stri-
dor, which is most often seen in anxious adolescents and young
adult [23]
There have been various reported frequencies of cough dur-
ing emergence from anesthesia. It is reported that they occur in
96% patients after extubation [24]. Also, such cough responses
occur from the chemically or mechanically sensitive ascending
vagus nerve [25]. However, cough responses are also affected
by other ascending nerves and organs, the thorax, the dia-
phragm, and nerves connected to the abdominal muscles. It
is not clear whether propofol can specifically suppress
responses to airway irritation, yet there has been a report that
it might be due to the diminishing effect of propofol on laryn-
geal responses. Also, propofol is considered to effectively sup-
press N-methyl-D-aspartate (NMDA) receptors and block the
ascending pathway from the trachea [26].as number percentage).
roup M (n= 40) Chi-square test
C vs. P C vs. M P vs. M
(42.5%) 0.007 0.005 0.862
(37.5%) 0.045 0.049 0.857
(10%) 0.025 0.018 0.739
(10%) 0.005 0.002 0.705
18 A.A. ShabanOur study also showed that both midazolam and propofol
groups are associated with a significant and comparable
increase in HR and decrease in MAP (but still within normal
ranges) after administration of the study drugs and up to
5 min after extubation compared to control group. Propofol
can significantly decrease the arterial pressure according to
the dosage used during anesthetic induction [27], and this
appears in relation to systemic vascular resistance and a
decrease in cardiac output. In addition, it does not have a sig-
nificant direct effect on HR, but it may increase [28]. In
another study, a subhypnotic dose (0.3 mg/kg) of propofol
can significantly increase the MAP and HR from the discontin-
uation of anesthetic drugs and up to 10 min in PACU. These
results are considered to be because only a small dose of
propofol was used in this study, and it did not have a signifi-
cant effect on the change in MAP and HR during emergence.
Another study shows significant decrease in the mean arterial
pressure and heart rate in both propofol and midazolam
groups after administration of the study drugs, and this
decrease was comparable and similar in both groups, which
is directly attributed to the relief from anxiety and hypoxia
associated with laryngospasm.
Two potential limitations should be considered. First, the
sample size enrolled in our study was limited to adult patients,
and hence, it cannot predict the coughing suppression effect of
propofol during emergence in pediatric patients receiving the
same doses scheduled in our study, so further investigations
are needed on wider population with different ages in order
to concur our results, to confirm their safety, and to support
the absence of any complications. Second, there are difficulties
in adequately blinding studies as propofol is white solution.
However, neither the surgeon nor the anesthesiologist con-
ducting assessment was aware of the group allocation. We
can conclude that the use of Propofol in a small dose
(0.8 mg kg1 body weight) or midazolam (0.05 mg kg1 body
weight) found to be useful drugs to relieve postextubation
laryngeal spasm in most patients undergoing oropharyngeal
surgeries. Because it was not found to be effective in all
patients, succinylcholine still has a role to play in critical con-
ditions. However, we recommend propofol or midazolam as a
suitable alternative for relieving laryngeal spasm in situations
where succinylcholine is contraindicated.
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